MedTrace Logo

Efficacy and Safety of TJ-100 in the Treatment of Chronic Constipation

NCT00522093 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-08-23

No results posted yet for this study

Summary

TJ-100, a Japanese herbal medicine, is clinically effective in postoperative ileus. So it may activate bowel movement. This study will test the efficacy and safety of TJ-100 in the treatment of patients with chronic constipation.

Conditions

  • Chronic Constipation

Interventions

DRUG

TJ-100

TJ-100 2.5g three times per day for 6 weeks

Sponsors & Collaborators

  • Tsumura USA

    collaborator INDUSTRY

  • Showa Inan General Hospital

    lead OTHER

Principal Investigators

  • Akira Horiuchi, M.D. · Showa Inan General Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00522093 on ClinicalTrials.gov